Key Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.35K Buy
65
+16
+33% +$1.87K ﹤0.01% 362
2026
Q1
$5.89K Sell
49
-50
-51% -$5.77K ﹤0.01% 364
2025
Q4
$10.4K Buy
+99
New +$9.29K 0.01% 272

Other funds holding MRK

Key Capital Management's MRK Position: Q2 2026 in Review

Key Capital Management increased its Merck (MRK) stake by 33% in Q2 2026, buying an estimated $1.87K and bringing the position to 65 shares worth $8.35K. The position accounts for ﹤0.01% of the portfolio, ranked #362.

Key Capital Management first reported a position in MRK in Q4 2025 and has held it in 3 quarters since. The position peaked at $10.4K in Q4 2025. 2,371 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Key Capital Management held 65 shares of Merck worth $8.35K as of Q2 2026.
  • Key Capital Management bought 16 Merck shares in Q2 2026, an estimated $1.87K.
  • Merck made up ﹤0.01% of Key Capital Management's portfolio in Q2 2026, its #362 holding.
  • Key Capital Management first reported a position in Merck in Q4 2025 and has held it in 3 quarters since.
  • Key Capital Management's Merck position peaked at $10.4K in Q4 2025.
  • 2,371 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Key Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.